Further, the expression of CDK1, TOP2A, AURKB, CDCA8, CCNE1, and CDC25B were at higher levels in GC tumors, and high expression of RNABP2, CDC25B, CDC25A, CCNE1, and TPR was associated with poor patient prognosis. Here, CDC25A is linked to gastric cancer.